Clark William D — SEC insider filings

SEC reporting owner CIK 1355415. 15 insider filings on record with FilingPulse; latest filed 2026-10-15.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2020-11-10 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GENOCEA BIOSCIENCES, INC. (GNCA)President and CEO, Director71 leg · 4,760 sh · $9,8064 legs · 136,626 sh · $24,9599
iBio, Inc. (IBIO)Director61 leg · 1,838 sh · $4,999—5
Aldeyra Therapeutics, Inc. (ALDX)Director2——3

Insider filings — Clark William D

FiledFormIssuerReported transactionsSource
2026-10-154iBio, Inc. (IBIO)Grant/award (A): 38,000 (derivative) @ $0EDGAR
2026-06-114Aldeyra Therapeutics, Inc. (ALDX)Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0EDGAR
2025-11-244iBio, Inc. (IBIO)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2025-04-184Aldeyra Therapeutics, Inc. (ALDX)Grant/award (A): 76,760 (derivative) @ $0EDGAR
2025-01-134iBio, Inc. (IBIO)Purchase (P): 1,838 @ $2.72EDGAR
2024-11-254iBio, Inc. (IBIO)Grant/award (A): 18,900 (derivative) @ $0EDGAR
2022-06-034GENOCEA BIOSCIENCES, INC. (GNCA)Sale (S): 4,023 @ $0.06EDGAR
2022-06-024GENOCEA BIOSCIENCES, INC. (GNCA)Sale (S): 117,244 @ $0.06EDGAR
2022-04-054GENOCEA BIOSCIENCES, INC. (GNCA)Sale (S): 3,924 @ $1.25EDGAR
2022-03-174GENOCEA BIOSCIENCES, INC. (GNCA)Grant/award (A): 150,000 @ $0 · Sale (S): 11,435 @ $1.10 · Grant/award (A): 450,000 (derivative) @ $0EDGAR
2021-12-134iBio, Inc. (IBIO)Grant/award (A): 109,000 (derivative) @ $0EDGAR
2021-08-254iBio, Inc. (IBIO)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174GENOCEA BIOSCIENCES, INC. (GNCA)Grant/award (A): 150,000 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0EDGAR
2021-02-184GENOCEA BIOSCIENCES, INC. (GNCA)Option exercise (M): 16,500 @ $1.66 · Option exercise (M): 19,998 @ $2.72 · Option exercise (M): 19,998 (derivative) @ $0 · Option exercise (M): 16,500 (derivative) @ $0EDGAR
2020-11-104GENOCEA BIOSCIENCES, INC. (GNCA)Purchase (P): 4,760 @ $2.06EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1355415 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs